Modulation of S6 fibrillation by unfolding rates and gatekeeper residues

Journal of Molecular Biology

Volumn 341, Issue 2, 2004, Pages 575-588

  Pedersen, Jesper Søndergaard ^a   Christensen, Gunna ^b   Otzen, Daniel Erik ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

D, denatured state; fibrillation; flexibility; GdmCl, guanidinium chloride; kinetics; protein engineering; TFE, trifluoroethanol; unfolding; GdmCl 50 , midpoint GdmCl concentration of denaturation

Indexed keywords

POLYPEPTIDE; PROTEIN S6;

ARTICLE; BEHAVIOR; CORRELATION ANALYSIS; KINETICS; MODULATION; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RESIDUE ANALYSIS; SPECIES; THERMOPHILIC BACTERIUM; THERMUS THERMOPHILUS;

PYRONIA TITHONUS; THERMUS; THERMUS THERMOPHILUS;

EID: 3342902033     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.06.020     Document Type: Article

References (54)

1. Rochet J.-C., Lansbury P.T. Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10:2000;60-68
2. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24:1999;329-332
3. Serpell L.C., Sunde M., Blake C.C.F. The molecular basis of amyloidosis. Cell. Mol. Life. Sci. 53:1997;871-887
4. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA. 96:1999;3590-3594
5. Fandrich M., Fletcher M.A., Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature. 410:2001;165-166
6. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., Blake C.C.F. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273:1997;729-739
7. Kelly J.W. Alternative conformations of amyloidogenic proteins govern their behaviour. Curr. Opin. Struct. Biol. 6:1996;11-17
8. Hilbich C., Kisters-Woike B., Reed J., Masters C., Beyreuther K. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218:1991;149-163
9. Jarrett J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemsitry. 32:1993;4693-4697
10. Esler W.P., Stimson E.R., Ghilardi J.R., Lu Y.A., Felix A.M., Vinters H.V., et al. Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry. 35:1996;13914-13921
11. Helms L.R., Wetzel R. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis. J. Mol. Biol. 257:1996;77-86
12. Azriel R., Gazit E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation. J. Biol. Chem. 276:2001;34156-34161
13. Thompson A.J., Barnham K.J., Norton R.S., Barrow C.J. The Val-210-Ile pathogenic Creutzfeldt-Jakob disease mutation increases both the helical and aggregation propensities of a sequence corresponding to helix-3 of PrP(C). Biochim. Biophys. Acta. 1544:2001;242-254
14. Salmona M., Malesani P., De Gioia L., Gorla S., Bruschi M., Molinari A., et al. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126. Biochem. J. 342:1999;207-214
15. Giasson B.I., Murray I.V., Trojanowski J.Q., Lee V.M. A hydrophobic stretch of 12 amino acid residues in the middle of synuclein is essential for filament assembly. J. Biol. Chem. 276:2001;2380-2386
16. Li L., Von Bergen M., Mandelkow E.M., Mandelkow E. Structure, stability, and aggregation of paired helical filaments from tau protein and FTDP-17 mutants probed by tryptophan scanning mutagenesis. J. Biol. Chem. 277:2002;41390-41400
17. Chiti F., Taddei N., Baroni F., Capanni C., Stefani M., Ramponi G., Dobson C.M. Kinetic partitioning of protein folding and aggregation. Nature Struct. Biol. 9:2002;137-143
18. Chiti F., Stefani M., Taddei N., Ramponi G., Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature. 424:2003;805-808
19. López de la Paz M., Goldie K., Zurdo J., Lacroix E., Dobson C.M., Hoenger A., Serrano L. De novo designed peptide-based amyloid fibrils. Proc. Natl Acad. Sci. USA. 99:2002;16052-16057
20. Chiti F., Calamai M., Taddei N., Stefani M., Ramponi G., Dobson C.M. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl Acad. Sci. USA. 99:2002;16419-16426
21. Chiba T., Hagihara Y., Higurashi T., Hasegawa K., Naiki H., Goto Y. Amyloid fibril formation in the context of full-length protein. J. Biol. Chem. 278:2003;47016-47024
22. Lomakin A., Chung D.S., Benedek G.B., Kirschner D.A., Teplow D.B. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl Acad. Sci. USA. 93:1996;1125-1129
23. Wood S.J., Wypych J., Steavenson S., Louis J.C., Citron M., Biere A.L. Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J. Biol. Chem. 274:1999;19509-19512
24. Nielsen L., Khurana R., Coats A., Frøkjær S., Brange J., Vyas S., Uversky V.N., Fink A.L. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry. 40:2001;6036-6046
25. Otzen D.E., Kristensen O., Proctor M., Oliveberg M. Structural changes in the transition state of protein folding: an alternative interpretation of curved chevron plots. Biochemistry. 38:1999;6499-6511
26. Otzen D.E., Oliveberg M. Salt-induced detour through compact regions of the protein folding landscape. Proc. Natl Acad. Sci. USA. 96:1999;11746-11751
27. Otzen D.E., Oliveberg M. Conformational plasticity in folding of the split β-α-β protein S6: evidence for burst-phase disruption of the native state. J. Mol. Biol. 317:2002;613-627
28. Otzen D.E., Kristensen P., Oliveberg M. Designed protein tetramer zipped together with an Alzheimer sequence: a structural clue to amyloid assembly. Proc. Natl Acad. Sci. USA. 97:2000;9907-9912
29. Chiti F., Taddei N., Bucciantini M., White P., Ramponi G., Dobson C.M. Mutational analysis of the propensity for amyloid formation by a globular protein. EMBO J. 19:2000;1441-1449
30. Zhang S., Holmes T., Lockshin C., Rich A. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc. Natl Acad. Sci. USA. 90:1993;3334-3338
31. Caplan M.R., Schwartzfarb E.M., Zhang S., Kamm R.D., Lauffenburger D.A. Effects of systematic variation of amino acid sequence on the mechanical properties of a self-assembling, oligopeptide biomaterial. J. Biomater. Sci. Polym. Ed. 13:2002;225-236
32. Srinivasan R., Jones E.M., Liu K., Ghiso J., Marchant R.E., Zagorski M.G. pH-dependent amyloid and protofibril formation by the ABri peptide of Familial British Dementia. J. Mol. Biol. 333:2003;1003-1023
33. Klunk W.E., Jacob R.F., Mason R.P. Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol. 309:1999;285-305
34. Klunk W.E., Jacob R.F., Mason R.P. Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red-Aβ (CR-Aβ) spectrophotometric method. Anal. Biochem. 266:1999;66-70
35. Levine H.I. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309:1999;274-284
36. Lindahl M., Svensson L.A., Liljas A., Sedelnikova S.E., Eliseikina I.A., Fomenkova N.P. Crystal structure of the ribosomal protein S6 from Thermus thermophilus. EMBO J. 13:1994;1249-1254
37. Tanford C. Protein denaturation. Part C. Theoretical models for the mechanism of denaturation. Advan. Protein Chem. 24:1970;1-95
38. Lakowicz J.R. Principles of Fluorescence Spectroscopy. 2nd edit.:1999;Kluwer Academic/Plenum, New York
39. Engelhard M., Evans P.A. Kinetics of interaction of partially folded proteins with a hydrophobic dye: evidence that molten globule character is maximal in early folding intermediates. Protein Sci. 4:1995;1553-1562
40. Ptitsyn O.B. Molten globule and protein folding. Advan. Protein Chem. 47:1995;83-229
41. Nielsen L., Khurana R., Coats A., Frøkjær S., Brange J., Vyas S., et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry. 40:2001;6036-6046
42. Souillac P.O., Uversky V.N., Millett I.S., Khurana R., Doniach S., Fink A.L. Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. J. Biol. Chem. 277:2002;12666-12679
43. Hammarström P., Jiang X., Hurshman A.R., Powers E.T., Kelly J.W. Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity. Proc. Natl Acad. Sci. USA. 99:2002;16427-16432
44. Yutani K., Takayama G., Goda S., Yamagata Y., Maki S., Namba K. The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile Pyrococcus furiosus. Biochemistry. 39:2000;2769-2777
45. Booth D.R., Sunde M., Bellotti V., Robinson C.V., Hutchinson W.L., Fraser P.E., et al. Instability, unfolding and fibrillogenesis in amyloidogenic lysozyme variants. Nature. 385:1997;787-793
46. Neira J.L., Itzhaki L.S., Ladurner A.G., Davis B., de Prat Gay G., Fersht A.R. Following co-operative formation of secondary and tertiary structure in a single protein module. J. Mol. Biol. 268:1997;185-197
47. Kortemme T., Kelly M.J., Kay L.E., Forman-Kay J.D., Serrano L. Similarities between the spectrin SH3 domain denatured state and its folding transition state. J. Mol. Biol. 297:2000;1217-1229
48. Lai Z., McCulloch J., Kelly J.W. GdmCl-induced denaturation and refolding of transthyretin exhibits marked hysteresis: equilibria with high kinetic barriers. Biochemistry. 36:1997;10230-10239
49. Funahashi J., Takano K., Ogasahara K., Yamagata Y., Uutani K. The structure, stability and folding process of amyloidogenic mutant human lysozyme. J. Biochem. 120:1996;1216-1223
50. Schuler B., Rachel R., Seckler R. Formation of fibrous aggregates from a non-native intermediate: the isolated P22 tailspike beta-helix domain. J. Biol. Chem. 274:1999;18589-18596
51. Kayed R., Bernhagen J., Greenfield N., Sweimeh K., Brunner H., Voelter W., Kapurniota A. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287:1999;781-796
52. Gerhartz B., Ekiel I., Abrahamson M. Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C. Biochemistry. 37:1998;17309-17317
53. Fink A.L. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des. 3:1998;R9-R29
54. Klemm P., Christiansen G. Three film genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae. Mol. Gen. Genet. 208:1987;439-445